
Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation
Keywords: Calcineurin; Cyclosporin A; Diabetes; FK506; Huntington's disease; R6/2 mouse; Neurodegeneration